Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.290
-0.070 (-2.97%)
At close: Dec 5, 2025, 4:00 PM EST
2.313
+0.023 (0.99%)
After-hours: Dec 5, 2025, 5:46 PM EST
Traws Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2.85 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
| Revenue Growth (YoY) | 1159.29% | - | - | - | -2.17% | -89.42% | Upgrade
|
| Gross Profit | 2.85 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
| Selling, General & Admin | 9.67 | 12.29 | 9.09 | 8.45 | 9.43 | 8.33 | Upgrade
|
| Research & Development | 8.97 | 12.85 | 11.43 | 11.41 | 7.3 | 16.9 | Upgrade
|
| Operating Expenses | 18.63 | 25.14 | 20.52 | 19.85 | 16.72 | 25.22 | Upgrade
|
| Operating Income | -15.79 | -24.91 | -20.3 | -19.63 | -16.5 | -24.99 | Upgrade
|
| Interest & Investment Income | 0.51 | 0.51 | 1.39 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.22 | -0.22 | -0.04 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.19 | -24.44 | - | 0.66 | 0.33 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | -13.31 | -49.06 | -18.95 | -18.96 | -16.16 | -25.15 | Upgrade
|
| Pretax Income | -13.31 | -166.52 | -18.95 | -18.96 | -16.16 | -25.15 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 0 | Upgrade
|
| Earnings From Continuing Operations | -13.31 | -166.52 | -18.95 | -18.96 | -16.16 | -25.16 | Upgrade
|
| Net Income | -13.31 | -166.52 | -18.95 | -18.96 | -16.16 | -25.16 | Upgrade
|
| Preferred Dividends & Other Adjustments | -4.15 | -111.85 | - | - | - | - | Upgrade
|
| Net Income to Common | -9.16 | -54.67 | -18.95 | -18.96 | -16.16 | -25.16 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 570.57% | 84.94% | 0.39% | 24.22% | 45.07% | 1109.88% | Upgrade
|
| EPS (Basic) | -1.38 | -35.21 | -22.57 | -22.68 | -24.01 | -54.21 | Upgrade
|
| EPS (Diluted) | -1.38 | -35.21 | -22.57 | -22.75 | -24.01 | -54.21 | Upgrade
|
| Free Cash Flow | -19.47 | -29.79 | -17.95 | -16.29 | -19.49 | -23.09 | Upgrade
|
| Free Cash Flow Per Share | -2.92 | -19.19 | -21.38 | -19.48 | -28.94 | -49.75 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -554.64% | -11022.12% | -8981.42% | -8684.51% | -7299.12% | -10819.48% | Upgrade
|
| Profit Margin | -321.72% | -24192.03% | -8384.07% | -8391.15% | -7151.77% | -10890.48% | Upgrade
|
| Free Cash Flow Margin | -684.01% | -13182.30% | -7940.71% | -7209.74% | -8622.57% | -9995.67% | Upgrade
|
| EBITDA | -15.77 | -24.9 | -20.28 | -19.61 | -16.48 | -24.98 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -15.79 | -24.91 | -20.3 | -19.63 | -16.5 | -24.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.